Researchers developed a framework to differentiate PD- from non-PD-related pain and classify PD-related pain into 3 groups — nociceptive, neuropathic, or nociplastic.
Study authors determined the impact of pimavanserin on cognitive function in patients with neuropsychiatric manifestations of neurodegenerative disease.
With cannabis in the United States becoming more widely available for medical and recreational use, some with Parkinson disease (PD) are trying cannabis to control symptoms. However, not that much is currently known about the attitudes and experiences regarding cannabis use among those with PD.
With no conclusive preclinical diagnostic test for Parkinson disease, diagnosis is achieved primarily through observations by a physician of the decline in motor functions. And while studies of sebum are commonplace in dermatological conditions, sebum as a biofluid has rarely been used in disease diagnostics.
Tori Rodriguez, MA, LPC, discusses chronic pain among patients with Parkinson disease and the breakdown of disease subtypes, classification, and pathophysiology.
While comorbidities with mental disorders are common in those with Parkinson Disease (PD), it is unclear whether PD is associated with an increased risk of suicide.
